Loading clinical trials...

Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNPhase 3NCT02427893

Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma

This trial explores the immunologic effects of vemurafenib (BRAF inhibitor) and cobimetinib (MEK inhibitor), administered alone and in combination, to patients with advanced BRAF V600E/K mutant melano...

Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

NCT06594991 · Advanced Melanoma

RECRUITINGPhase 1

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425 · Solid Tumours, Melanoma

RECRUITINGPhase 2

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

NCT02621021 · Melanoma

RECRUITINGPhase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

RECRUITINGNA

Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

NCT07564570 · Metastatic Melanoma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 15, 2016Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE3

Enrollment—

Start dateAug 2015

Last updatedNov 15, 2016

Condition

Melanoma

Locations shown

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 15, 2016Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions